These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
77-0259 335
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
|
ý
|
Accelerated filer
|
¨
|
|
|
|
|
|
|
Non-accelerated filer
|
¨
(Do not check if a smaller reporting company)
|
Smaller reporting company
|
¨
|
|
|
|
|
|
|
|
|
Page
|
|
PART I: FINANCIAL INFORMATION
|
|
|
|
|
|
Item 1. Financial Statements
|
|
|
|
|
|
|
|
|
|
October 1, 2016
|
|
January 2, 2016
|
||||
|
ASSETS
|
|||||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
164,552
|
|
|
$
|
179,915
|
|
|
Short term investments
|
38,179
|
|
|
33,124
|
|
||
|
Accounts receivable, net of allowance of $29 at October 1, 2016 and $33 at January 2, 2016
|
67,612
|
|
|
104,679
|
|
||
|
Unbilled revenue
|
139
|
|
|
452
|
|
||
|
Inventory
|
61,069
|
|
|
61,678
|
|
||
|
Other current assets
|
10,357
|
|
|
9,501
|
|
||
|
Total current assets
|
341,908
|
|
|
389,349
|
|
||
|
Property and equipment, net
|
26,745
|
|
|
26,850
|
|
||
|
Deferred tax assets
|
26,018
|
|
|
31,721
|
|
||
|
Goodwill
|
41,041
|
|
|
48,751
|
|
||
|
Intangible assets, net
|
13,071
|
|
|
15,664
|
|
||
|
Other assets
|
9,843
|
|
|
9,408
|
|
||
|
Total assets
|
$
|
458,626
|
|
|
$
|
521,743
|
|
|
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND
STOCKHOLDERS’ EQUITY
|
|||||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
57,662
|
|
|
$
|
61,655
|
|
|
Accrued expenses
|
13,662
|
|
|
15,954
|
|
||
|
Accrued compensation
|
17,257
|
|
|
15,752
|
|
||
|
Deferred revenue and customer advances
|
1,297
|
|
|
3,265
|
|
||
|
Total current liabilities
|
89,878
|
|
|
96,626
|
|
||
|
Long term liabilities
|
4,231
|
|
|
7,706
|
|
||
|
Commitments and contingencies (Note 7)
|
|
|
|
|
|
||
|
Redeemable convertible preferred stock, 5,000,000 shares authorized and none outstanding
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par value, 100,000,000 shares authorized; 26,970,474 and 29,091,806 shares issued and outstanding at October 1, 2016 and January 2, 2016, respectively
|
270
|
|
|
291
|
|
||
|
Additional paid-in capital
|
150,998
|
|
|
232,345
|
|
||
|
Retained earnings
|
213,269
|
|
|
185,011
|
|
||
|
Accumulated other comprehensive loss
|
(20
|
)
|
|
(236
|
)
|
||
|
Total stockholders’ equity
|
364,517
|
|
|
417,411
|
|
||
|
Total liabilities, redeemable convertible preferred stock and stockholders’ equity
|
$
|
458,626
|
|
|
$
|
521,743
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
October 1, 2016
|
|
September 26, 2015
|
||||||||
|
Revenue
|
$
|
168,610
|
|
|
$
|
143,609
|
|
|
$
|
448,110
|
|
|
$
|
410,358
|
|
|
Cost of revenue (1)
|
87,550
|
|
|
73,751
|
|
|
235,437
|
|
|
216,759
|
|
||||
|
Gross margin
|
81,060
|
|
|
69,858
|
|
|
212,673
|
|
|
193,599
|
|
||||
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
|
Research and development (1)
|
19,672
|
|
|
18,122
|
|
|
57,944
|
|
|
55,886
|
|
||||
|
Selling and marketing (1)
|
17,925
|
|
|
19,379
|
|
|
66,972
|
|
|
60,896
|
|
||||
|
General and administrative (1)
|
16,012
|
|
|
13,701
|
|
|
48,919
|
|
|
39,195
|
|
||||
|
Total operating expenses
|
53,609
|
|
|
51,202
|
|
|
173,835
|
|
|
155,977
|
|
||||
|
Operating income
|
27,451
|
|
|
18,656
|
|
|
38,838
|
|
|
37,622
|
|
||||
|
Other income (expense), net
|
523
|
|
|
(93
|
)
|
|
2,142
|
|
|
(948
|
)
|
||||
|
Income before income taxes
|
27,974
|
|
|
18,563
|
|
|
40,980
|
|
|
36,674
|
|
||||
|
Income tax expense
|
8,462
|
|
|
5,770
|
|
|
12,722
|
|
|
11,875
|
|
||||
|
Net income
|
$
|
19,512
|
|
|
$
|
12,793
|
|
|
$
|
28,258
|
|
|
$
|
24,799
|
|
|
Net income per share
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.72
|
|
|
$
|
0.43
|
|
|
$
|
1.01
|
|
|
$
|
0.84
|
|
|
Diluted
|
$
|
0.70
|
|
|
$
|
0.42
|
|
|
$
|
0.99
|
|
|
$
|
0.82
|
|
|
Number of weighted average common shares used in calculations per share
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
27,237
|
|
|
29,654
|
|
|
27,878
|
|
|
29,697
|
|
||||
|
Diluted
|
27,778
|
|
|
30,117
|
|
|
28,423
|
|
|
30,253
|
|
||||
|
(1)
|
Total stock-based compensation recorded in the three and nine months ended
October 1, 2016
and
September 26, 2015
included in the above figures breaks down by expense classification as follows:
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
October 1, 2016
|
|
September 26, 2015
|
|||||||
|
Cost of revenue
|
$
|
184
|
|
|
$
|
270
|
|
|
$
|
555
|
|
|
662
|
|
|
Research and development
|
1,028
|
|
|
963
|
|
|
2,598
|
|
|
2,737
|
|
|||
|
Selling and marketing
|
444
|
|
|
474
|
|
|
1,316
|
|
|
1,089
|
|
|||
|
General and administrative
|
2,247
|
|
|
2,193
|
|
|
7,312
|
|
|
5,974
|
|
|||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
October 1, 2016
|
|
September 26, 2015
|
||||||||
|
Net income
|
$
|
19,512
|
|
|
$
|
12,793
|
|
|
$
|
28,258
|
|
|
$
|
24,799
|
|
|
Other comprehensive income, net of tax:
|
|
|
|
|
|
|
|
||||||||
|
Unrealized gains/(losses) on investments, net of tax
|
(66
|
)
|
|
67
|
|
|
216
|
|
|
25
|
|
||||
|
Total comprehensive income
|
$
|
19,446
|
|
|
$
|
12,860
|
|
|
$
|
28,474
|
|
|
$
|
24,824
|
|
|
|
Nine Months Ended
|
||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income
|
$
|
28,258
|
|
|
$
|
24,799
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
10,171
|
|
|
10,569
|
|
||
|
Loss on disposal of assets
|
205
|
|
|
201
|
|
||
|
Gain on sale of business unit
|
(433
|
)
|
|
—
|
|
||
|
Gain on sale of cost method investment
|
(634
|
)
|
|
—
|
|
||
|
Stock-based compensation
|
11,781
|
|
|
10,462
|
|
||
|
Deferred income taxes, net
|
6,314
|
|
|
2,289
|
|
||
|
Tax benefit of excess stock-based compensation deductions
|
(1,115
|
)
|
|
(795
|
)
|
||
|
Non-cash director deferred compensation
|
66
|
|
|
112
|
|
||
|
Changes in operating assets and liabilities — (use) source
|
|
|
|
||||
|
Accounts receivable
|
30,781
|
|
|
(5,258
|
)
|
||
|
Unbilled revenue
|
198
|
|
|
2,034
|
|
||
|
Inventory
|
(11,472
|
)
|
|
(10,965
|
)
|
||
|
Other assets
|
(1,579
|
)
|
|
1,296
|
|
||
|
Accounts payable
|
(2,261
|
)
|
|
(1,285
|
)
|
||
|
Accrued expenses
|
(2,046
|
)
|
|
(6,127
|
)
|
||
|
Accrued compensation
|
1,990
|
|
|
(5,082
|
)
|
||
|
Deferred revenue and customer advances
|
(193
|
)
|
|
(1,570
|
)
|
||
|
Long term liabilities
|
(2,997
|
)
|
|
(703
|
)
|
||
|
Net cash provided by operating activities
|
67,034
|
|
|
19,977
|
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Additions of property and equipment
|
(8,352
|
)
|
|
(7,557
|
)
|
||
|
Change in other assets
|
(435
|
)
|
|
(1,015
|
)
|
||
|
Proceeds from sale of business unit
|
23,520
|
|
|
—
|
|
||
|
Purchases of investments
|
(16,556
|
)
|
|
(17,755
|
)
|
||
|
Sales of investments
|
11,502
|
|
|
18,000
|
|
||
|
Proceeds from sale of cost method investments
|
634
|
|
|
—
|
|
||
|
Net cash provided by (used in) investing activities
|
10,313
|
|
|
(8,327
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Proceeds from stock option exercises
|
4,496
|
|
|
3,385
|
|
||
|
Income tax withholding payment associated with restricted stock vesting
|
(1,300
|
)
|
|
(1,295
|
)
|
||
|
Stock repurchases
|
(97,021
|
)
|
|
(24,062
|
)
|
||
|
Tax benefit of excess stock-based compensation deductions
|
1,115
|
|
|
795
|
|
||
|
Net cash used in financing activities
|
(92,710
|
)
|
|
(21,177
|
)
|
||
|
Net decrease in cash and cash equivalents
|
(15,363
|
)
|
|
(9,527
|
)
|
||
|
Cash and cash equivalents, at beginning of period
|
179,915
|
|
|
185,957
|
|
||
|
Cash and cash equivalents, at end of period
|
$
|
164,552
|
|
|
$
|
176,430
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
|
Cash paid for income taxes
|
$
|
11,818
|
|
|
$
|
8,791
|
|
|
Non-cash investing and financing activities:
|
|
|
|
||||
|
Stock repurchases included in accrued expenses
|
$
|
—
|
|
|
$
|
1,156
|
|
|
Transfer of inventory to property and equipment
|
$
|
5
|
|
|
$
|
157
|
|
|
Additions of property and equipment included in accounts payable
|
$
|
694
|
|
|
$
|
754
|
|
|
Asset retirement obligation
|
$
|
115
|
|
|
$
|
—
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
(In thousands, except per share amounts)
|
||||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
October 1, 2016
|
|
September 26, 2015
|
||||||||
|
Net income
|
$
|
19,512
|
|
|
$
|
12,793
|
|
|
$
|
28,258
|
|
|
$
|
24,799
|
|
|
Weighted-average shares outstanding
|
27,237
|
|
|
29,654
|
|
|
27,878
|
|
|
29,697
|
|
||||
|
Dilutive effect of employee stock options and restricted shares
|
541
|
|
|
463
|
|
|
545
|
|
|
556
|
|
||||
|
Diluted weighted-average shares outstanding
|
27,778
|
|
|
30,117
|
|
|
28,423
|
|
|
30,253
|
|
||||
|
Basic income per share
|
$
|
0.72
|
|
|
$
|
0.43
|
|
|
$
|
1.01
|
|
|
$
|
0.84
|
|
|
Diluted income per share
|
$
|
0.70
|
|
|
$
|
0.42
|
|
|
$
|
0.99
|
|
|
$
|
0.82
|
|
|
|
Fair Value Measurements as of
October 1, 2016
|
||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||
|
|
(In thousands)
|
||||||||||
|
Description
|
|
|
|
|
|
||||||
|
Assets:
|
|
|
|
|
|
||||||
|
Cash and cash equivalents
|
|
|
|
|
|
||||||
|
Money market funds
|
$
|
108,751
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Short term investments
|
|
|
|
|
|
||||||
|
Corporate and government bonds (1)
|
—
|
|
|
38,179
|
|
|
—
|
|
|||
|
Other current assets
|
|
|
|
|
|
||||||
|
Derivative instruments (Note 6) (2)
|
—
|
|
|
16
|
|
|
—
|
|
|||
|
Total assets measured at fair value
|
$
|
108,751
|
|
|
$
|
38,195
|
|
|
$
|
—
|
|
|
|
Fair Value Measurements as of
January 2, 2016 |
||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||
|
|
(In thousands)
|
||||||||||
|
Description
|
|
|
|
|
|
||||||
|
Assets:
|
|
|
|
|
|
||||||
|
Cash and cash equivalents
|
|
|
|
|
|
||||||
|
Money market funds
|
$
|
110,817
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Short term investments
|
|
|
|
|
|
||||||
|
Corporate and government bonds (1)
|
—
|
|
|
33,124
|
|
|
—
|
|
|||
|
Total assets measured at fair value
|
$
|
110,817
|
|
|
$
|
33,124
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
||||||
|
Liabilities:
|
|
|
|
|
|
||||||
|
Accrued Expenses
|
|
|
|
|
|
||||||
|
Derivative instruments (Note 6) (2)
|
$
|
—
|
|
|
$
|
28
|
|
|
$
|
—
|
|
|
Total liabilities measured at fair value
|
$
|
—
|
|
|
$
|
28
|
|
|
$
|
—
|
|
|
(1)
|
The bond investments are valued based on observable market values as of the Company’s reporting date. The bond investments are recorded at fair value and marked-to-market at the end of each reporting period. The realized and unrealized gains and losses are included in comprehensive income for that period.
|
|
(2)
|
Derivative instruments are valued using an income approach based on the present value of the forward rate less the contract rate multiplied by the notional amount.
|
|
|
October 1, 2016
|
|
January 2, 2016
|
||||
|
|
(In thousands)
|
||||||
|
Raw materials
|
$
|
4,021
|
|
|
$
|
9,082
|
|
|
Finished goods
|
57,048
|
|
|
52,596
|
|
||
|
|
$
|
61,069
|
|
|
$
|
61,678
|
|
|
|
October 1, 2016
|
|
January 2, 2016
|
||||
|
|
(In thousands)
|
||||||
|
Accrued warranty
|
$
|
7,847
|
|
|
$
|
6,907
|
|
|
Accrued rent
|
492
|
|
|
547
|
|
||
|
Accrued direct fulfillment costs
|
759
|
|
|
2,030
|
|
||
|
Accrued customer deposits
|
980
|
|
|
788
|
|
||
|
Accrued sales tax
|
187
|
|
|
625
|
|
||
|
Accrued accounting fees
|
459
|
|
|
395
|
|
||
|
Accrued sales commissions
|
183
|
|
|
465
|
|
||
|
Accrued other
|
2,755
|
|
|
4,197
|
|
||
|
|
$
|
13,662
|
|
|
$
|
15,954
|
|
|
|
October 1, 2016
|
|
January 2, 2016
|
||||
|
|
(In thousands)
|
||||||
|
Accrued bonus
|
$
|
9,597
|
|
|
$
|
8,640
|
|
|
Accrued other compensation
|
7,660
|
|
|
7,112
|
|
||
|
|
$
|
17,257
|
|
|
$
|
15,752
|
|
|
|
|
|
Notional amount
|
|
Fair Value
|
||||||||||||
|
|
Classification
|
|
October 1, 2016
|
|
January 2, 2016
|
|
October 1, 2016
|
|
January 2, 2016
|
||||||||
|
|
|
|
(In thousands)
|
||||||||||||||
|
Foreign currency forward contracts
|
Other current assets
|
|
$
|
3,533
|
|
|
$
|
—
|
|
|
$
|
16
|
|
|
$
|
—
|
|
|
Foreign currency forward contracts
|
Accrued expenses
|
|
$
|
—
|
|
|
$
|
6,773
|
|
|
$
|
—
|
|
|
$
|
28
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
Classification
|
|
October 1, 2016
|
|
September 26, 2015
|
|
October 1, 2016
|
|
September 26, 2015
|
||||||||
|
|
|
|
(In thousands)
|
||||||||||||||
|
Derivatives not designated as hedging instruments
|
|
|
|
|
|
|
|
|
|||||||||
|
Gain (loss) recognized in income
|
Other income (expense), net
|
|
$
|
(18
|
)
|
|
$
|
191
|
|
|
$
|
(392
|
)
|
|
$
|
(1
|
)
|
|
|
Operating
Leases
|
||
|
|
(In thousands)
|
||
|
Remainder of 2016
|
$
|
990
|
|
|
2017
|
4,595
|
|
|
|
2018
|
4,458
|
|
|
|
2019
|
4,216
|
|
|
|
2020
|
2,126
|
|
|
|
Thereafter
|
3,228
|
|
|
|
Total minimum lease payments
|
$
|
19,613
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
October 1, 2016
|
|
September 26, 2015
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Balance at beginning of period
|
$
|
6,622
|
|
|
$
|
7,081
|
|
|
$
|
6,907
|
|
|
$
|
7,769
|
|
|
Provision
|
2,823
|
|
|
1,031
|
|
|
5,619
|
|
|
3,182
|
|
||||
|
Warranty usage (1)
|
(1,598
|
)
|
|
(1,236
|
)
|
|
(4,679
|
)
|
|
(4,075
|
)
|
||||
|
Balance at end of period
|
$
|
7,847
|
|
|
$
|
6,876
|
|
|
$
|
7,847
|
|
|
$
|
6,876
|
|
|
(1)
|
Warranty usage includes costs incurred for warranty obligations and, for the nine-month period ended October 1, 2016, the release of warranty liabilities associated with the divestiture of the defense and security business unit.
|
|
|
October 1, 2016
|
|
January 2, 2016
|
||||||||||||||||||||
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||
|
|
(In thousands)
|
||||||||||||||||||||||
|
Completed technology
|
$
|
26,900
|
|
|
$
|
13,829
|
|
|
$
|
13,071
|
|
|
$
|
26,900
|
|
|
$
|
11,236
|
|
|
$
|
15,664
|
|
|
Trade name
|
100
|
|
|
100
|
|
|
—
|
|
|
100
|
|
|
100
|
|
|
—
|
|
||||||
|
Total
|
$
|
27,000
|
|
|
$
|
13,929
|
|
|
$
|
13,071
|
|
|
$
|
27,000
|
|
|
$
|
11,336
|
|
|
$
|
15,664
|
|
|
|
(In thousands)
|
||
|
Remainder of 2016
|
$
|
864
|
|
|
2017
|
3,457
|
|
|
|
2018
|
3,457
|
|
|
|
2019
|
2,818
|
|
|
|
2020
|
900
|
|
|
|
Thereafter
|
1,575
|
|
|
|
Total
|
$
|
13,071
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||
|
|
October 1, 2016
|
|
October 1, 2016
|
||||
|
|
(in thousands)
|
||||||
|
Balance at beginning of period
|
$
|
477
|
|
|
$
|
—
|
|
|
Charges
|
155
|
|
|
1,857
|
|
||
|
Utilization
|
(361
|
)
|
|
(1,586
|
)
|
||
|
Balance at end of period
|
$
|
271
|
|
|
$
|
271
|
|
|
|
|
|
|
||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
October 1, 2016
|
|
September 26, 2015
|
||||
|
Revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of revenue
|
51.9
|
|
|
51.4
|
|
|
52.5
|
|
|
52.8
|
|
|
Gross margin
|
48.1
|
|
|
48.6
|
|
|
47.5
|
|
|
47.2
|
|
|
Operating expenses
|
|
|
|
|
|
|
|
||||
|
Research and development
|
11.7
|
|
|
12.6
|
|
|
13.0
|
|
|
13.6
|
|
|
Selling and marketing
|
10.6
|
|
|
13.5
|
|
|
14.9
|
|
|
14.8
|
|
|
General and administrative
|
9.5
|
|
|
9.5
|
|
|
10.9
|
|
|
9.6
|
|
|
Total operating expenses
|
31.8
|
|
|
35.6
|
|
|
38.8
|
|
|
38.0
|
|
|
Operating income
|
16.3
|
|
|
13.0
|
|
|
8.7
|
|
|
9.2
|
|
|
Other expense, net
|
0.3
|
|
|
(0.1
|
)
|
|
0.4
|
|
|
(0.2
|
)
|
|
Income before income taxes
|
16.6
|
|
|
12.9
|
|
|
9.1
|
|
|
9.0
|
|
|
Income tax expense
|
5.0
|
|
|
4.0
|
|
|
2.8
|
|
|
3.0
|
|
|
Net income
|
11.6
|
%
|
|
8.9
|
%
|
|
6.3
|
%
|
|
6.0
|
%
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
|
|
(In thousands)
|
|
|
|
|
|
(In thousands)
|
|
|
||||
|
Total revenue
|
$168,610
|
|
$143,609
|
|
$25,001
|
|
17.4%
|
|
$448,110
|
|
$410,358
|
|
$37,752
|
|
9.2%
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||
|
Total cost of revenue
|
$87,550
|
|
$73,751
|
|
$13,799
|
|
18.7%
|
|
$235,437
|
|
$216,759
|
|
$18,678
|
|
8.6%
|
|
As a percentage of total revenue
|
51.9%
|
|
51.4%
|
|
|
|
|
|
52.5%
|
|
52.8%
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||
|
Total gross margin
|
$81,060
|
|
$69,858
|
|
$11,202
|
|
16.0%
|
|
$212,673
|
|
$193,599
|
|
$19,074
|
|
9.9%
|
|
As a percentage of total revenue
|
48.1%
|
|
48.6%
|
|
|
|
|
|
47.5%
|
|
47.2%
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||
|
Total research and development
|
$19,672
|
|
$18,122
|
|
$1,550
|
|
8.6%
|
|
$57,944
|
|
$55,886
|
|
$2,058
|
|
3.7%
|
|
As a percentage of total revenue
|
11.7%
|
|
12.6%
|
|
|
|
|
|
13.0%
|
|
13.6%
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||
|
Total selling and marketing
|
$17,925
|
|
$19,379
|
|
$(1,454)
|
|
(7.5)%
|
|
$66,972
|
|
$60,896
|
|
$6,076
|
|
10.0%
|
|
As a percentage of total revenue
|
10.6%
|
|
13.5%
|
|
|
|
|
|
14.9%
|
|
14.8%
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||
|
Total general and administrative
|
$16,012
|
|
$13,701
|
|
$2,311
|
|
16.9%
|
|
$48,919
|
|
$39,195
|
|
$9,724
|
|
24.8%
|
|
As a percentage of total revenue
|
9.5%
|
|
9.5%
|
|
|
|
|
|
10.9%
|
|
9.6%
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||
|
Total other income (expense), net
|
$523
|
|
$(93)
|
|
$616
|
|
(662.4)%
|
|
$2,142
|
|
$(948)
|
|
$3,090
|
|
(325.9)%
|
|
As a percentage of total revenue
|
0.3%
|
|
(0.1)%
|
|
|
|
|
|
0.4%
|
|
(0.2)%
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
October 1, 2016
|
|
September 26, 2015
|
|
Dollar
Change
|
|
Percent
Change
|
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||
|
Total income tax expense
|
$8,462
|
|
$5,770
|
|
$2,692
|
|
46.7%
|
|
$12,722
|
|
$11,875
|
|
$847
|
|
7.1%
|
|
As a percentage of pre-tax income
|
30.2%
|
|
31.1%
|
|
|
|
|
|
31.0%
|
|
32.4%
|
|
|
|
|
|
|
(a) Total number of Shares Purchased (1)
|
(b) Average Price Paid per Share (2)
|
(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
(d) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
|
||||||
|
Period
|
|
|
|
|
||||||
|
Fiscal month beginning July 3, 2016 and ended July 30, 2016
|
—
|
|
|
$—
|
|
—
|
|
|
$—
|
|
|
Fiscal month beginning July 31, 2016 and ended August 27, 2016
|
—
|
|
—
|
|
—
|
|
—
|
|
||
|
Fiscal month beginning August 28, 2016 and ended October 1, 2016
|
359,000
|
|
37.49
|
|
359,000
|
|
—
|
|
||
|
Total
|
359,000
|
|
|
$37.49
|
|
359,000
|
|
|
$—
|
|
|
(1)
|
Consists of shares of our common stock. All repurchases were made in open market transactions and pursuant to our previously-announced stock repurchase program. This represents shares purchased to date through October 1, 2016 and not the final number of shares to be repurchased.
|
|
(2)
|
On March 1, 2016, we entered into an accelerated share repurchase (“ASR”) agreement with J.P. Morgan Securities LLC, as agent for JPMorgan Chase Bank, National Association, London Branch (“JPMorgan”), to repurchase an aggregate of $85.0 million of our common stock. Pursuant to the ASR agreement, we paid JPMorgan $85.0 million in April 2016 and received an initial delivery of 1,900,862 shares of our common stock. In September 2016, the ASR reached its scheduled termination and we received an additional 359,000 shares with a final delivery of 7,542 in early October 2016. The calculation of the average price per share for the period July 3, 2016 to October 1, 2016 in the table above is based solely on the result of dividing the $85.0 million we paid towards the ASR in the second quarter of 2016 by the total shares received under the plan of 2,267,404.
|
|
Exhibit
Number
|
|
Description
|
|
31.1*
|
|
Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
31.2*
|
|
Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
32.1**
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
101*
|
|
The following materials from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2016 formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, and (v) related notes to these financial statements
|
|
*
|
Filed herewith
|
|
**
|
Furnished herewith
|
|
|
iROBOT CORPORATION
|
|
|
|
|
|
|
Date: November 7, 2016
|
By:
|
/s/ Alison Dean
|
|
|
|
Alison Dean
|
|
|
|
Executive Vice President and Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer)
|
|
Exhibit
Number
|
|
Description
|
|
31.1*
|
|
Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
31.2*
|
|
Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
|
|
|
|
|
|
32.1**
|
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
|
101*
|
|
The following materials from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2016 formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Cash Flows, and (v) related notes to these financial statements
|
|
*
|
Filed herewith
|
|
**
|
Furnished herewith
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|